7.56 USD
+0.17
2.30%
At close Apr 17, 4:00 PM EDT
After hours
7.57
+0.01
0.13%
1 day
2.30%
5 days
3.14%
1 month
-18.27%
3 months
-33.10%
6 months
-35.44%
Year to date
-39.13%
1 year
-31.89%
5 years
-51.35%
10 years
-51.35%
 

About: Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Employees: 32,000

0
Funds holding %
of 7,407 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

43% more first-time investments, than exits

New positions opened: 139 | Existing positions closed: 97

17% more funds holding in top 10

Funds holding in top 10: 12 [Q3] → 14 (+2) [Q4]

13% more capital invested

Capital invested by funds: $10.9B [Q3] → $12.4B (+$1.46B) [Q4]

4.54% more ownership

Funds ownership: 78.82% [Q3] → 83.36% (+4.54%) [Q4]

2% more funds holding

Funds holding: 984 [Q3] → 1,008 (+24) [Q4]

0% more call options, than puts

Call options by funds: $35M | Put options by funds: $34.9M

18% less repeat investments, than reductions

Existing positions increased: 306 | Existing positions reduced: 374

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$9
19%
upside
Avg. target
$10.50
39%
upside
High target
$13
72%
upside

4 analyst ratings

positive
25%
neutral
25%
negative
50%
Jefferies
Glen Santangelo
45% 1-year accuracy
5 / 11 met price target
72%upside
$13
Buy
Maintained
7 Mar 2025
Piper Sandler
David Amsellem
44% 1-year accuracy
14 / 32 met price target
32%upside
$10
Neutral
Reiterated
5 Mar 2025
Barclays
Balaji Prasad
18% 1-year accuracy
8 / 44 met price target
19%upside
$9
Underweight
Maintained
28 Feb 2025
B of A Securities
Jason Gerberry
26% 1-year accuracy
5 / 19 met price target
32%upside
$10
Underperform
Maintained
28 Feb 2025

Financial journalist opinion

Based on 285 articles about VTRS published over the past 30 days

Neutral
GlobeNewsWire
5 hours ago
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS
NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the important June 3, 2025 lead plaintiff deadline.
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS
Neutral
PRNewsWire
5 hours ago
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit
NEW YORK , April 19, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the "Class Period"), of the important June 3, 2025 lead plaintiff deadline. So what: If you purchased Viatris securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit
Neutral
Accesswire
6 hours ago
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Viatris To Contact Him Directly To Discuss Their Options NEW YORK, NY / ACCESS Newswire / April 19, 2025 / If you suffered losses exceeding $100,000 in Viatris between August 8, 2024 and February 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Viatris, Inc. ("Viatris" or the "Company") (NASDAQ:VTRS) and reminds investors of the June 3, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
Neutral
GlobeNewsWire
6 hours ago
VTRS INVESTOR NEWS: Viatris Inc. Investors may be able to Recover Losses in Class Action Lawsuit -- Contact BFA Law before June 3 Deadline (NASDAQ:VTRS)
NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Viatris, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/viatris-inc.
VTRS INVESTOR NEWS: Viatris Inc. Investors may be able to Recover Losses in Class Action Lawsuit -- Contact BFA Law before June 3 Deadline (NASDAQ:VTRS)
Neutral
PRNewsWire
16 hours ago
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc. - VTRS
NEW ORLEANS , April 18, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 3, 2025 to file lead plaintiff applications in a securities class action lawsuit against Viatris Inc. ("Viatris" or "the Company") (NasdaqGS: VTRS), if they purchased the Company's securities between August 8, 2024 and February 26, 2025, inclusive (the "Class Period").  This action is pending in the United States District Court for the Western District of Pennsylvania.
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc. - VTRS
Neutral
Accesswire
20 hours ago
Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
NEW YORK, NY / ACCESS Newswire / April 18, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143980&wire=1 or contact Joseph E. Levi, Esq.
Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
Neutral
Accesswire
20 hours ago
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
NEW YORK CITY, NY / ACCESS Newswire / April 18, 2025 / WHY: New York, N.Y., April 18, 2025.
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
Neutral
Accesswire
22 hours ago
Viatris Inc. Class Action: Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - VTRS
NEW YORK, NY / ACCESS Newswire / April 18, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143956&wire=1 or contact Joseph E. Levi, Esq.
Viatris Inc. Class Action: Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - VTRS
Neutral
Accesswire
22 hours ago
Contact Levi & Korsinsky by June 3, 2025 Deadline to Join Class Action Against Viatris Inc. (VTRS)
NEW YORK, NY / ACCESS Newswire / April 18, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=143945&wire=1 or contact Joseph E. Levi, Esq.
Contact Levi & Korsinsky by June 3, 2025 Deadline to Join Class Action Against Viatris Inc. (VTRS)
Neutral
GlobeNewsWire
22 hours ago
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Viatris Inc. (“Viatris” or “the Company”) (NASDAQ: VTRS) and certain of its officers.
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Charts implemented using Lightweight Charts™